Why did China's battery giant CATL shares surge?
How will Trump's tariffs impact global retailers?
Why did Home Depot warn of softer sales?
What caused the U.S. credit rating downgrade?
How is JPMorgan responding to crypto market shifts?
Why did Nike cut tech jobs and outsource work?
What’s driving the EU and UK post-Brexit deal?
How will Regeneron's 23andMe acquisition affect biotech?
Why are mortgage rates rising after Moody’s downgrade?
Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal
benzinga.com/general/health-care/25/05/45510221/pfizer-secures-global-rights-to-chinas-3sbios-cancer-drug-in-6-billion-deal
Pfizer Inc. (NYSE:PFE) announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.‘s bispecific antibody SSGJ-707 in a deal potentially worth up to $6 billion.
The agreement includes a $1.25 billion upfront payment to the Chinese biopharmaceutical company, with…
This story appeared on benzinga.com, 2025-05-20 03:55:56.